No Data
No Data
We're Not Very Worried About Contineum Therapeutics' (NASDAQ:CTNM) Cash Burn Rate
Morgan Stanley Maintains Contineum Therapeutics(CTNM.US) With Buy Rating, Announces Target Price $25
Analysts Are Bullish on Top NA Stocks: Unusual Machines Inc. (UMAC), Contineum Therapeutics, Inc. Class A (CTNM)
Contineum Therapeutics Appoints Diego Miralles to Board
Contineum Therapeutics Announces Appointment of Diego Miralles, M.D. to Its Bd of Directors
JonesTrading Initiates Contineum Therapeutics(CTNM.US) With Buy Rating, Announces Target Price $23